GlassScriptPhysician profile
Carlo Nicolis
NPI 1841226909
$3,258.06
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $447 · 2021: $608 · 2022: $1,119 · 2023: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $443.24 | 2019-2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $433.82 | 2019-2021 | |
| Pfizer INC. | $340.64 | 2019-2022 | |
| Myovant Sciences INC. | $291.45 | 2021-2022 | |
| Janssen Biotech, INC. | $254.40 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $190.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $181.89 | 2019-2022 | |
| Teleflex LLC | $160.12 | 2022 | |
| Abbvie INC. | $121.53 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $106.45 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $103.53 | 2020-2022 | |
| Urogen Pharma, INC. | $92.03 | 2021-2022 | |
| Amgen INC. | $85.09 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $68.29 | 2022 | |
| Allergan, INC. | $56.42 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $54.76 | 2021-2022 | |
| Axonics, INC. | $50.94 | 2022-2023 | Axonics |
| Clinigen, INC. | $45.00 | 2019-2020 | |
| Boston Scientific Corporation | $43.39 | 2021-2022 | |
| Angiodynamics, INC. | $39.35 | 2021-2023 | Bioflo |
| Blue Earth Diagnostics | $37.35 | 2021-2022 | |
| Baxter Healthcare | $16.23 | 2021 | |
| Endo Pharmaceuticals INC. | $14.98 | 2019 | |
| Coloplast Corp | $14.20 | 2022 | |
| Foundation Medicine, INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlo Nicolis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.